TG
TRV GP Portfolio holdings
AUM
$18.9M
This Quarter Return
+14.95%
1 Year Return
+541.67%
3 Year Return
+3,178.87%
5 Year Return
–
10 Year Return
–
AUM
$221M
AUM Growth
–
Cap. Flow
+$221M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$116M |
| 2 |
CytomX Therapeutics
CTMX
|
$70.1M |
| 3 |
KALA BIO
KALA
|
$30.6M |
| 4 |
Carisma Therapeutics
CARM
|
$3.92M |
| 5 |
Larimar Therapeutics
LRMR
|
$972K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $116M | 52.29% | +3,981,437 | New | +$116M |
|
|
2
CytomX Therapeutics
CTMX
$336M
| $70.1M | 31.68% | +3,320,348 | New | +$70.1M |
|
|
3
KALA BIO
KALA
$78.8M
| $30.6M | 13.82% | +1,654,425 | New | +$30.6M |
|
|
4
Carisma Therapeutics
CARM
$8.98M
| $3.92M | 1.77% | +4,841,591 | New | +$3.92M |
|
|
5
Larimar Therapeutics
LRMR
$310M
| $972K | 0.44% | +210,371 | New | +$972K |
|